RecruitingNCT02328677

ColoCare Study - Colorectal Cancer Cohort

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis


Sponsor

University of Utah

Enrollment

5,000 participants

Start Date

Mar 1, 2007

Study Type

OBSERVATIONAL

Conditions

Summary

ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Inclusion Criteria5

  • Age 18-89 years; for patients recruited after 09/01/2021 the age range is 18-69 years. Recruitment of patients 70 years and older was maintained for specific sub-studies and re-initiated for specific R01 grant funding in \~06/2024
  • Men and women
  • Newly-diagnosed colon or rectal cancer (stages I-IV); CRC in treatment (FHCRC and HCI)
  • English (FHCRC, Moffitt, HCI, Cedars-Sinai, WashU St. Louis) or German (University Hospital Heidelberg)-speaking;
  • mentally/physically able to consent and participate.

Exclusion Criteria2

  • if one of the above in not fulfilled
  • insufficient language or consent capacity

Locations(7)

Cedars-Sinai Medical Center

Los Angeles, California, United States

Lee H. Moffitt Cancer Center

Tampa, Florida, United States

Washington University School of Medicine

St Louis, Missouri, United States

University of Tennessee

Knoxville, Tennessee, United States

Huntsman Cancer Institute

Salt Lake City, Utah, United States

FHCRC

Seattle, Washington, United States

University Hospital Heidelberg

Heidelberg, Baden-Wurttemberg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02328677


Related Trials